Müller-Holzner E - Search Results

1

Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.

Marth C, Windbichler G, Petru E, Dirschlmayer W, Obermair A, Czerwenka K, Müller-Holzner E, Dapunt O. Marth C, et al. Gynecol Oncol. 1997 Jan;64(1):121-5. doi: 10.1006/gyno.1996.4538. Gynecol Oncol. 1997. PMID: 8995559

2

Fulminant course of a microinvasive vulvar carcinoma in an immunosuppressed woman.

Volgger B, Marth C, Zeimet A, Müller-Holzner E, Ruth N, Dapunt O. Volgger B, et al. Gynecol Oncol. 1997 Apr;65(1):177-9. doi: 10.1006/gyno.1997.4632. Gynecol Oncol. 1997. PMID: 9103410

3

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.

Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Müller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C. Zeimet AG, et al. J Clin Oncol. 1998 May;16(5):1861-8. doi: 10.1200/JCO.1998.16.5.1861. J Clin Oncol. 1998. PMID: 9586902

4

Interferon-gamma expression is an independent prognostic factor in ovarian cancer.

Marth C, Fiegl H, Zeimet AG, Müller-Holzner E, Deibl M, Doppler W, Daxenbichler G. Marth C, et al. Am J Obstet Gynecol. 2004 Nov;191(5):1598-605. doi: 10.1016/j.ajog.2004.05.007. Am J Obstet Gynecol. 2004. PMID: 15547530

5

Validation of intraoperative risk assessment on frozen section for surgical management of endometrial carcinoma.

Egle D, Grissemann B, Zeimet AG, Müller-Holzner E, Marth C. Egle D, et al. Gynecol Oncol. 2008 Sep;110(3):286-92. doi: 10.1016/j.ygyno.2008.05.007. Epub 2008 Jul 23. Gynecol Oncol. 2008. PMID: 18653219

6

Modulation of ovarian carcinoma OV632 antigen by interferons.

Marth C, Müller-Holzner E, Gaugg I, Daxenbichler G, Dapunt O. Marth C, et al. Oncology. 1992;49(1):53-7. doi: 10.1159/000227011. Oncology. 1992. PMID: 1542495

7

[Prognostically relevant factors in malignant mixed Müllerian tumor].

Marth C, Koza A, Müller-Holzner E, Hetzel H, Fuith LC, Dapunt O. Marth C, et al. Geburtshilfe Frauenheilkd. 1990 Aug;50(8):605-9. doi: 10.1055/s-2008-1026309. Geburtshilfe Frauenheilkd. 1990. PMID: 2170227 German.

8

Prognostic value of CD44 splice variant expression in ovarian cancer.

Uhl-Steidl M, Müller-Holzner E, Zeimet AG, Adolf GR, Daxenbichler G, Marth C, Dapunt O. Uhl-Steidl M, et al. Oncology. 1995 Sep-Oct;52(5):400-6. doi: 10.1159/000227497. Oncology. 1995. PMID: 7543667

9

Significance of thrombocytosis in patients with epithelial ovarian cancer.

Zeimet AG, Marth C, Müller-Holzner E, Daxenbichler G, Dapunt O. Zeimet AG, et al. Am J Obstet Gynecol. 1994 Feb;170(2):549-54. doi: 10.1016/s0002-9378(94)70225-x. Am J Obstet Gynecol. 1994. PMID: 8116711

10

[Biochemical prognostic factors in oncology].

Marth C, Zeimet AG, Müller-Holzner E, Steidl M, Windbichler G, Daxenbichler G, Dapunt O. Marth C, et al. Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:197-8. doi: 10.1159/000272215. Gynakol Geburtshilfliche Rundsch. 1993. PMID: 8118267 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters